Alzheimer's Disease Market
Alzheimer's Disease Market Size, Share & Trends Analysis Report
Alzheimer's Disease Market Size, Share & Trend Analysis By Stage of Disease (Early-stage Alzheimer's disease, Mild to moderate Alzheimer's disease,Severe Alzheimer's disease), By Healthcare Component (Treatment/Therapy, Service, Diagnosis), By Healthcare Facility (Home care, Specialty Clinics, Nursing homes, Diagnostic Centers, Others) Based On Region, And Segment Forecasts 2029
Published
Report ID : BMRC 2597
Number of pages : 300
Published Date : May 2023
Category : Healthcare
Delivery Timeline : 48 hrs
Segments
By Stage of Disease
- Early-stage Alzheimer's disease
- Mild to moderate Alzheimer's disease
- Severe Alzheimer's disease
By Healthcare Component
-
Treatment/Therapy
- Cholinesterase inhibitors
- NMDA receptor antagonists
- Others
- Service
-
Diagnosis
- Imaging technology
- Magnetic resonance imaging (MRI)
- Computed tomography (CT)
- Positron emission tomography (PET)
- Biomarkers
- Others
By Healthcare Facility
- Home care
- Specialty Clinics
- Nursing homes
- Diagnostic Centers
- Others
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
- F. Hoffmann-La Roche AG
- Novartis AG
- Thermo Fisher Scientific, Inc.
- AstraZeneca PLC
- Ixico plc
- Siemens Healthineers AG
- Neurotrack Technologies, Inc.
- Johnson & Johnson
- Accera, Inc.
- Cerveau Technologies Inc.
